Collapsin response mediator protein-2 (CRMP2) is a plausible etiological factor and potential therapeutic target in Alzheimer’s disease: Comparison and contrast with microtubule-associated protein tau

Manuscript Number: 

16-0076R1

Author(s): 
Kenneth Hensley, Petri Kursula

Disclosures

Kenneth Hensley

  • Equity:
    Equity position in XoNovo Inc., co-founder
    Patents/Royalties
    Inventor of licensed patent regarding lanthionine ketimine derivatives
    Grants
    • Agency: 
      XoNovo / FuturX
      Dates: 
      May 1 2015-present

Petri Kursula

  • Nothing to Disclose